Antennapedia and HIV transactivator of transcription (TAT) "protein transduction domains" promote endocytosis of high molecular weight cargo upon binding to cell surface glycosaminoglycans
- PMID: 12837762
- DOI: 10.1074/jbc.M301726200
Antennapedia and HIV transactivator of transcription (TAT) "protein transduction domains" promote endocytosis of high molecular weight cargo upon binding to cell surface glycosaminoglycans
Abstract
Protein transduction domains (PTDs) are short basic peptide sequences present in many cellular and viral proteins that mediate translocation across cellular membranes. PTDs have become widely used as tools for the delivery of high Mr polypeptides, polynucleotides, or nanoparticles to cells in culture; and even the transfer of cargo molecules to the tissue of live animals has been reported. These cell-permeable peptides are functional when fused in-frame to recombinant polypeptides or when chemically coupled to their cargo. The mechanism responsible for PTD-mediated membrane translocation is controversially discussed and may vary among the various PTDs reported in the literature. Thus direct physical interaction with membrane lipids resulting in vectorial delivery to cells has been proposed for the Antennapedia (Antp) PTD, whereas uptake by the retroviral TAT (transactivator of transcription) protein PTD seems to require cell surface-expressed glycosaminoglycans. The view that PTD-mediated cellular uptake is energy-independent has been dismissed recently as an artifact resulting from fixation of cells. The data reported here agree with and further extend this work. They support the idea that certain PTDs promote cellular uptake via endocytosis and require the expression of negatively charged glycosaminoglycans on the surface of the target cells. Uptake of Antp PTD conjugates or peptide-derivatized liposomes was blocked by heparan sulfate proteoglycans, whereas TAT-mediated uptake was inhibited by both heparin and dextran sulfate. Mutant cells defective for glycosaminoglycan synthesis showed dramatically reduced Antp- or TAT-mediated transmembrane transport confirming the role of these complex polysaccharides in PTD-mediated cellular uptake. The fact that PTDs selectively interact with distinct glycosaminoglycan species has implications for therapeutic applications and may allow targeting of selective tissues that differ in their surface-expressed glycosaminoglycan patterns.
Similar articles
-
Protein transduction domains fused to virus receptors improve cellular virus uptake and enhance oncolysis by tumor-specific replicating vectors.J Virol. 2004 Dec;78(24):13743-54. doi: 10.1128/JVI.78.24.13743-13754.2004. J Virol. 2004. PMID: 15564483 Free PMC article.
-
Comparative study on transduction and toxicity of protein transduction domains.Br J Pharmacol. 2008 Mar;153(6):1143-52. doi: 10.1038/sj.bjp.0707678. Epub 2008 Jan 28. Br J Pharmacol. 2008. PMID: 18223668 Free PMC article.
-
Enhanced heparan sulfate proteoglycan-mediated uptake of cell-penetrating peptide-modified liposomes.Cell Mol Life Sci. 2004 Jul;61(14):1785-94. doi: 10.1007/s00018-004-4166-0. Cell Mol Life Sci. 2004. PMID: 15241554 Free PMC article.
-
Intracellular transduction and potential of Tat PTD and its analogs: from basic drug delivery mechanism to application.Expert Opin Drug Deliv. 2012 Apr;9(4):457-72. doi: 10.1517/17425247.2012.663351. Expert Opin Drug Deliv. 2012. PMID: 22432469 Review.
-
Biological applications of protein transduction technology.Trends Biotechnol. 2003 Nov;21(11):498-503. doi: 10.1016/j.tibtech.2003.09.008. Trends Biotechnol. 2003. PMID: 14573363 Free PMC article. Review.
Cited by
-
Comparative study of the skin penetration of protein transduction domains and a conjugated peptide.Pharm Res. 2005 May;22(5):750-7. doi: 10.1007/s11095-005-2591-x. Epub 2005 May 17. Pharm Res. 2005. PMID: 15906170
-
In vitro cellular uptake and neuroprotective efficacy of poly-arginine-18 (R18) and poly-ornithine-18 (O18) peptides: critical role of arginine guanidinium head groups for neuroprotection.Mol Cell Biochem. 2020 Jan;464(1-2):27-38. doi: 10.1007/s11010-019-03646-0. Epub 2019 Nov 2. Mol Cell Biochem. 2020. PMID: 31679100
-
The design of guanidinium-rich transporters and their internalization mechanisms.Adv Drug Deliv Rev. 2008 Mar 1;60(4-5):452-72. doi: 10.1016/j.addr.2007.10.016. Epub 2007 Nov 9. Adv Drug Deliv Rev. 2008. PMID: 18164781 Free PMC article. Review.
-
Current Development of siRNA Bioconjugates: From Research to the Clinic.Front Pharmacol. 2019 Apr 26;10:444. doi: 10.3389/fphar.2019.00444. eCollection 2019. Front Pharmacol. 2019. PMID: 31105570 Free PMC article. Review.
-
Peptide-mediated cellular delivery of oligonucleotide-based therapeutics in vitro: quantitative evaluation of overall efficacy employing easy to handle reporter systems.Curr Pharm Des. 2008;14(34):3637-55. doi: 10.2174/138161208786898806. Curr Pharm Des. 2008. PMID: 19075740 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources